EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Molecular DNA dendron vaccines

Max E Distler iD, John P Cavaliere, Michelle H Teplensky, Michael Evangelopoulos iD, Chad A Mirkin iD

Proceedings of the National Academy of Sciences · 2023

DOI: 10.1073/pnas.2215091120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2023. Verfasst von Max E Distler und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Northwestern University, Evanston, IL 60208. Hauptthemen laut MEDLINE: Vaccines, DNA, Dendrimers, Cancer Vaccines, Uterine Cervical Neoplasms. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, DOD | USAF | AMC | Air Force Office of Scientific Research, HHS | NIH | National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A foundational principle of rational vaccinology is that vaccine structure plays a critical role in determining therapeutic efficacy, but in order to establish fundamental, effective, and translatable vaccine design parameters, a highly modular and well-defined platform is required. Herein, we report a DNA dendron vaccine, a molecular nanostructure that consists of an adjuvant DNA strand that splits into multiple DNA branches with a varied number of conjugated peptide antigens that is capable of dendritic cell uptake, immune activation, and potent cancer killing. We leveraged the well-defined architecture and chemical modularity of the DNA dendron to study structure-function relationships that dictate molecular vaccine efficacy, particularly regarding the delivery of immune-activating DNA sequences and antigenic peptides on a single chemical construct. We investigated how adjuvant and antigen placement and number impact dendron cellular uptake and immune activation, in vitro. These parameters also played a significant role in raising a potent and specific immune response against target cancer cells. By gaining this structural understanding of molecular vaccines, DNA dendrons successfully treated a mouse cervical human papillomavirus TC-1 cancer model, in vivo, where the vaccine structure defined its efficacy; the top-performing design effectively reduced tumor burden (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vaccines, DNADendrimersCancer VaccinesUterine Cervical NeoplasmsPapillomavirus VaccinesAnimalsFemaleMiceHumansDNAPeptidesAnthracenes

Stichwörter der Autor:innen

DNA dendronsDNA therapeuticsvaccines

Substanzen

Vaccines, DNADendrimersCancer VaccinesDNAPeptidesPapillomavirus VaccinesdendronAnthracenes

Autor:innen und Institutionen

  • Department of Chemistry, Northwestern University, Evanston, IL 60208.
  • International Institute for Nanotechnology, Northwestern University, Evanston, IL 60208.
  • Department of Biomedical Engineering, Northwestern University, Evanston, IL 60208.

ORCID-Profile: Max E Distler, Michael Evangelopoulos, Chad A Mirkin

Förderung

  • NCI NIH HHS
  • DOD | USAF | AMC | Air Force Office of Scientific Research
  • HHS | NIH | National Cancer Institute
  • HHS | National Institutes of Health
  • National Science Foundation

Zitieren

APA

Distler, M. E., Cavaliere, J. P., Teplensky, M. H., Evangelopoulos, M., & Mirkin, C. A. (2023). Molecular DNA dendron vaccines. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2215091120

Vancouver

Distler ME, Cavaliere JP, Teplensky MH, Evangelopoulos M, Mirkin CA. Molecular DNA dendron vaccines. Proceedings of the National Academy of Sciences. 2023. doi:10.1073/pnas.2215091120

BibTeX
@article{Distler2023,
  author = {Distler, Max E and Cavaliere, John P and Teplensky, Michelle H and Evangelopoulos, Michael and Mirkin, Chad A},
  title = {Molecular DNA dendron vaccines},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2023},
  doi = {10.1073/pnas.2215091120}
}
Kostenlos starten →